A Biosynthetic Platform for Antimalarial Drug Discovery.

Area of Science:

• Synthetic biology
• Microbiology
• Medicinal chemistry

Background:

• Synthetic biology enables bacterial production of complex compounds.
• Violacein, an indole pigment, has antibiotic properties and can be engineered in E. coli.
• Exploring bacterial biosynthesis for drug discovery is crucial.

Purpose of the Study:

• Screen bacterially derived violacein for antimalarial activity against Plasmodium falciparum.
• Evaluate a series of violacein derivatives for efficacy.
• Investigate the mode of action of violacein in P. falciparum.

Main Methods:

• Engineered Escherichia coli for violacein biosynthesis.
• Screened violacein and derivatives against P. falciparum strains (3D7, drug-sensitive, and drug-resistant).
• Analyzed the effect of violacein on the parasite actin cytoskeleton.

Main Results:

• Bacterially derived violacein demonstrated antiparasitic activity against P. falciparum.
• Violacein derivatives exhibited varied activity against asexual parasite growth.
• Violacein disrupted the parasite actin cytoskeleton, causing actin signal accumulation independent of polymerization.

Conclusions:

• Bacterial synthetic biosynthesis is a viable platform for antimalarial drug discovery.
• Violacein shows potential as an antimalarial agent, warranting further development.
• The mode of action involves modulation of the parasite actin cytoskeleton.